Proteome analysis of adipocyte lipid rafts reveals that gClqR plays essential roles in adipogenesis and insulin signal transduction

Proteomics

Volumn 9, Issue 9, 2009, Pages 2373-2382

  Kim, Ki Bum ^a   Kim, Bong Woo ^a   Choo, Hyo Jung ^a   Kwon, Young Chan ^a   Ahn, Byung Yoon ^a   Choi, Jong Soon ^b   Lee, Jae Seon ^c   Ko, Young Gyu ^a  

^a Korea University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Insulin resistance; Lipid raft; Signal transduction; Two dimensional difference gel electrophoresis

Indexed keywords

ACID PROTEIN; GLOBULAR C1Q RECEPTOR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; FUNCTIONAL PROTEOMICS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIPID RAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOGENESIS; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD44; CELL LINE; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; INSULIN; MEMBRANE MICRODOMAINS; MICE; MOLECULAR SEQUENCE DATA; PROTEOME; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 66249121051     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800811     Document Type: Article

References (49)

1. Simons, K., Toomre, D., Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1, 31-39.
2. Jacobson, K., Mouritsen, O. G., Anderson, R. G., Lipid rafts: at a crossroad between cell biology and physics. Nat. Cell Biol. 2007, 9, 7-14.
3. Patra, S. K., Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim. Biophys. Acta 2008, 1785, 182-206.
4. Brown, D. A., Rose, J. K., Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992, 68, 533-544.
5. Pelkmans, L., Helenius, A., Endocytosis via caveolae. Traffic 2002, 3,311-320.
6. Nabi, I. R., Le, P. U., Caveolae/raft-dependent endocytosis. J. Cell Biol. 2003, 161, 673-677.
7. Parton, R. G., Simons, K., The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 2007, 8, 185-194.
8. Parton, R. G., Caveolae - from ultrastructure to molecular mechanisms. Nat. Rev. Mol. Cell Biol. 2003, 4162-4167.
9. Anderson, R. G., The caveolae membrane system. Annu. Rev. Biochem. 1998, 67, 199-225.
10. Foster, L. J., De Hoog, C. L., Mann, M., Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc. Natl. Acad. Sci. USA 2003, 100, 5813-5818.
11. Bae, T. J., Kim, M. S., Kim, J. W., Kim, B. W. et al., Lipid raft proteome reveals ATP synthase complex in the cell surface. Proteomics 2004, 4, 3536-3548.
12. Kim, K. B., Lee, J. W., Lee, C. S., Kim, B. W. et al., Oxidation- reduction respiratorychains and ATP synthase complex are localized in detergent-resistant lipid rafts. Proteomics 2006, 6, 2444-2453.
13. McMahon, K. A., Zhu, M., Kwon, S. W., Liu, P. et al., Detergent-free caveolae proteome suggests an interaction with ER and mitochondria. Proteomics 2006, 6, 143-152.
14. Bernocco, S., Fondelli, C., Matteoni, S., Magnoni, L. et al., Sequential detergent fractionation of primary neurons for proteomics studies. Proteomics 2008, 8, 930-938.
15. Ikonen, E., Vainio, S., Lipid microdomains and insulin resistance: is there a connection? Sci. STKE 2005, p. e3.
16. Yamamoto, M., Toya, Y., Schwencke, C., Lisanti, M. P. et al., Caveolin is an activator ofinsulin receptor signaling. J. Biol. Chem. 1998, 273, 26962-26968.
17. Cohen, A. W., Razani, B., Wang, X. B., Combs, T. P. et al., Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am. J. Physiol., Cell Physiol. 2003, 285, C222-C235.
18. Scherer, P. E., Lisanti, M. P., Baldini, G., Sargiacomo, M. etal., Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell Biol. 1994, 127, 1233-1243.
19. Gustavsson, J., Parpal, S., Stralfors, P., Insulin-stimulated glucose uptake involves the transition ofglucose transporters to a caveolae-rich fraction within the plasma membrane: implications for type II diabetes. Mol. Med. 1996, 2, 367-372.
20. Baumann, C. A., Ribon, V., Kanzaki, M., Thurmond, D. C. et al., CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000, 407, 202-207.
21. Chiang, S. H., Baumann, C. A., Kanzaki, M., Thurmond, D. C. et al., Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001, 410, 944-948.
22. Saltiel, A. R., Pessin, J. E., Insulin signaling in microdomains ofthe plasma membrane. Traffic2003, 4,711-716.
23. Ghebrehiwet, B., Peerschke, E. I., Structure and function of gC1q-R: a multiligand binding cellular protein. Immuno-biology 1998, 199, 225-238.
24. Kim, B. W., Choo, H. J., Lee, J. W., Kim, J. H., Ko, Y. G., Extracellular ATP is generated by ATP synthase complex in adipocyte lipid rafts. Exp. Mol. Med. 2004, 36, 476-485.
25. Kim, K. B., Lee, J. S., Ko, Y. G., The isolation of detergent- resistant lipid rafts for two-dimensional electrophoresis. Methods Mol. Biol. 2008, 424, 413-422.
26. Liao, W., Nguyen, M. T., Yoshizaki, T., Favelyukis, S. et al., Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake byaffecting both GLUT1 and GLUT4 in 3T3- L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 2007, 293, E219-E227.
27. Peerschke, E. I., Reid, K. B., Ghebrehiwet, B., Identification of a novel 33 kDa C1q-binding site on human blood platelets. J. Immunol. 1994, 152,5896-5901.
28. Ghebrehiwet, B., Lim, B. L., Kumar, R., Feng, X., Peerschke, E. I., gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol. Rev. 2001, 180, 65-77.
29. Herwald, H., Dedio, J., Kellner, R., Loos, M., Muller-Esterl, W., Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J. Biol. Chem. 1996, 271, 13040-13047.
30. Lim, B. L., Reid, K. B., Ghebrehiwet, B., Peerschke, E. I. etal., The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor. J. Biol. Chem. 1996, 271, 26739-26744.
31. Lu, P. D., Galanakis, D. K., Ghebrehiwet, B., Peerschke, E. I., The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization. Clin. Immunol. 1999, 90, 360-367.
32. Gupta, S., Batchu, R. B., Datta, K., Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface. Eur. J. Cell Biol. 1991, 56, 58-67.
33. Ghebrehiwet, B., Peerschke, E. I., cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol. Immunol. 2004, 41, 173-183.
34. Welsh, G. I., Griffiths, M. R., Webster, K. J., Page, M. J., Tavare, J. M., Proteome analysis of adipogenesis. Proteom-ics 2004, 4, 1042-1051.
35. Kratchmarova, I., Kalume, D. E., Blagoev, B., Scherer, P. E. et al., A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell. Proteomics 2002, 1, 213-222.
36. Adachi, J., Kumar, C., Zhang, Y., Mann, M., In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics. Mol. Cell. Proteomics 2007, 6, 1257-1273.
37. Luo, Y., Yu, H., Peterlin, B. M., Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 1994, 68, 3850-3856.
38. Yu, L., Loewenstein, P. M., Zhang, Z., Green, M., In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J. Virol. 1995, 69, 3017-3023.
39. Braun, L., Ghebrehiwet, B., Cossart, P., gC1q-R/p32, a C1q- binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. EMBO J. 2000, 19, 1458-1466.
40. Kittlesen, D. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J., Hahn, Y. S., Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lympho- cyte proliferation. J. Clin. Invest. 2000, 106, 1239-1249.
41. Youngren, J. F., Regulation of insulin receptor function. Cell. Mol. Life Sci. 2007, 64, 873-891.
42. Maddux, B. A., Goldfine, I. D., Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes 2000, 49, 13-19.
43. Dong, H., Maddux, B. A., Altomonte, J., Meseck, M. et al., Increased hepatic levels of the insulin receptor inhibitor, PC- 1/NPP1, induce insulin resistance and glucose intolerance. Diabetes 2005, 54, 367-372.
44. Maddux, B. A., Chang, Y. N., Accili, D., McGuinness, O. P. et al., Overexpression of the insulin receptor inhibitor PC-1/ ENPP1 induces insulin resistance and hyperglycemia. Am. J. Physiol. Endocrinol. Metab. 2006, 290, E746-E749.
45. Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W. et al., Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283, 1544-1548.
46. Zabolotny, J. M., Haj, F. G., Kim, Y. B., Kim, H. J. et al., Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not addi- tively impair insulin action. J. Biol. Chem. 2004, 279, 24844-24851.
47. Bossenmaier, B., Mosthaf, L., Mischak, H., Ullrich, A., Haring, H. U., Protein kinase C isoforms beta 1 and beta 2 inhibit the tyrosine kinase activity of the insulin receptor. Diabetologia 1997, 40, 863-866.
48. Strack, V., Hennige, A. M., Krutzfeldt, J., Bossenmaier, B. et al., Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta. Diabetologia 2000, 43, 443-449.
49. Itani, S. I., Zhou, Q., Pories, W. J., MacDonald, K. G., Dohm, G. L., Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 2000, 49, 1353-1358.